The programmed site-specific delivery of LY3200882 and PD-L1 siRNA boosts immunotherapy for triple-negative breast cancer by remodeling tumor microenvironmentPan Zhang, Meirong Huo, Xuxin Chu et al.|Biomaterials|2022Cited by 68
Synchronous targeted delivery of TGF-β siRNA to stromal and tumor cells elicits robust antitumor immunity against triple-negative breast cancer by comprehensively remodeling the tumor microenvironmentMengmeng Yang, Lifang Yin, Chao Qin et al.|Biomaterials|2023Cited by 66